Despite being the first domestic company to list via De-SPAC on the HKEX, **ZG Group (06676.HK)** has struggled to gain investor confidence. As of January 29, 2026, its market value has shrunk by over 80%, with a market cap falling below HK$2 billion. The company remains caught in a cycle of "growing revenue but expanding losses," as its 1H 2025 net loss widened by 573.1% to RMB 499 million.
NewTimeSpace News: Zhejiang Rongtai Electric Material Co., Ltd. (603119.SH) officially submitted a listing application to the Stock Exchange of Hong Kong Limited on January 29, 2026, with CITIC Securities serving as the sole sponsor. According to a Frost & Sullivan report, the company ranked first in the global mica product market for the new energy sector with a 22.6% market share in terms of 2024 operating revenue.
NewTimeSpace News: Tian Ge Interactive Holdings Limited (01980.HK) announced that its public float has dropped to approximately 20.85% due to a takeover offer, failing to meet the minimum requirement under the Listing Rules. The company has applied to the Stock Exchange of Hong Kong (SEHK) for a five-month waiver and plans to restore the public float as soon as possible through measures such as placing new shares.
NewTimeSpace News,CONSUN PHARMA announced an upsized share repurchase plan via a 公告 on January 29. Based on the repurchase mandate previously granted by shareholders, the company will add a maximum of HK$100 million to the existing repurchase fund of no more than HK$200 million, with a total proposed fund deployment of up to HK$300 million for timely share repurchases on the open market.
NewTimeSpace News,HORIZON CD issued a profit warning on January 29, projecting that its total revenue in 2025 will decrease by nearly 20% compared with 2024, and the profit attributable to shareholders will drop by 70%-90%. The decline is mainly affected by factors such as the industry environment, business contraction, and slowed asset disposal scale.
NewTimeSpace News , BIOCYTOGEN-B released its 2025 annual performance forecast on January 29, disclosing an annual revenue of RMB 1.369 billion to RMB 1.389 billion, representing a year-on-year increase of 39.61% to 41.65%; the net profit attributable to shareholders of the parent company is expected to be RMB 162 million to RMB 182 million, surging 384.26% to 443.88% year-on-year.
While VISEN Pharmaceuticals officially entered the commercial stage with the NMPA approval of lonapegsomatropin on January 26, 2026, the market remains skeptical. The stock closed at HK$35.20 on January 28, representing a **48.84% drop** from its IPO price, as the company grapples with deep losses and a high-pressure competitive landscape.
January 28, 2026, EAST BUY(01797.HK) released its Interim Report for the period ended May 31, 2026, Total Revenue stood at CNY 2.31 billion, increased by 5.72% YoY
NewTimeSpace News: MMG Limited (01208.HK) announced on January 28 that the Company has entered into a one-year shipping framework agreement with Minmetals Shipping, a wholly-owned subsidiary of China Minmetals Corporation, the Company's ultimate controlling shareholder. Pursuant to the agreement, Minmetals Shipping will provide maritime transportation services for the shipment of the Group's products from Peru and Australia. The transaction constitutes a continuing connected transaction, with the annual transaction cap set at USD 39 million for the 2026 fiscal year.
NewTimeSpace News,TONGGUAN GOLD completed the partial conversion of convertible bonds on January 28 in accordance with the notice from the bondholder. It allotted 6 million new shares at a conversion price of HK$1.1 per share, corresponding to the converted bond principal of HK$6.6 million.
NewTimeSpace News, PROSP GP INTL announced that it has successfully completed the placement of 33.365 million new shares pursuant to the general mandate on January 28. The placement price is HK$0.34 per share, with net proceeds of approximately HK$10.54 million, which are intended to be fully used for the Group's general working capital.
NewTimeSpace News, ND PAPER issued a positive profit warning on January 28, expecting that for the six months ended December 31, 2025, the profit attributable to equity holders of the company will be between RMB 1.95 billion and RMB 2.05 billion, representing a substantial increase of 315.2% to 336.5% compared with the same period last year.
Seres was listed on the Hong Kong Stock Exchange on 5 November 2025 at an offer price of HK$131.50 per share; net proceeds were about HK$14.283 billion. The IPO brought in 22 cornerstone investors who subscribed a combined HK$6.421 billion. Since listing, the share price has remained below the offer price; as of 27 January 2026 the cumulative decline is roughly 25%. According to the company’s financial report, revenue for the first nine months of 2025 was RMB 110.534 billion and net profit rose 31.56% year-on-year. Revenue is highly dependent on the AITO brand, whose vehicle sales account for more than 90% of total turnover.
NewTimeSpace News: BEXCELLENT GP issued a positive profit forecast on January 27. For the four months ended November 30, 2025, the group's unaudited consolidated net profit attributable to owners of the company was approximately HK$3 million, turning around from a loss in the same period of the previous year.
NewTimeSpace News: The Stock Exchange of Hong Kong Limited (HKEX) announced on January 27 that it has imposed a reprimand and a declaration of unfitness to act as director against Mr. Yu Bin, former Executive Director and Chairman of Skyfame Realty (Holdings) Limited (00059.HK). The Exchange determined that Mr. Yu failed to fulfill his obligation to cooperate in investigations conducted by the Securities and Futures Commission (SFC) and HKEX’s Listing Division, in violation of the Listing Rules.
NewTimeSpace News: POLY PROPERTY issued a voluntary announcement on January 27, stating that its wholly-owned subsidiary Shanghai Poly Property successfully issued the second tranche of 2026 medium-term notes on January 22. The issuance scale is RMB500 million with a three-year term and a coupon rate of 2.95% per annum. The proceeds raised will be used to replace the own funds allocated for repaying debt financing instruments.
